Literature DB >> 7533789

Epstein-Barr virus-induced autoimmune responses. II. Immunoglobulin G autoantibodies to mimicking and nonmimicking epitopes. Presence in autoimmune disease.

J H Vaughan1, M D Nguyen, J R Valbracht, K Patrick, G H Rhodes.   

Abstract

During infectious mononucleosis, IgM autoantibodies are generated to a protein, p542, which contains a glycine-rich 28-mer epitope cross-reactive with the Epstein-Barr nuclear antigen-1 through Epstein-Barr nuclear antigen-1's glycine/alanine repeat. In normal individuals it is uncommon to find IgG anti-p542, but among patients with progressive systemic sclerosis, systemic lupus erythematosus, and ulcerative colitis high IgG anti-p542 (> 3 SD above the mean of normal 20-50 yr controls) occurred frequently. Lesser elevations occurred in Sjögren's syndrome, rheumatoid arthritis, ankylosing spondylitis, and Crohn's disease, but none with chronic hepatitis B infection. The reactive epitopes on p542 were mapped with deletion mutants, which indicated that the glycine-rich 28-mer was the major antigenic determinant, with lesser antibody responses to other epitopes. We conclude that normally there is an inability to generate IgG autoantibodies to the cross-reactive (mimicking) epitope of the p542 host protein, but that this inability is overcome in a proportion of patients with autoimmune disease. We conclude also that non-cross-reactive autoepitopes exist on p542 protein, to which IgG autoantibodies can commonly be formed in autoimmune disorders. The mechanisms responsible for the latter must involve different mechanisms than those responsible for autoantibodies to the mimicking epitope.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7533789      PMCID: PMC441471          DOI: 10.1172/JCI117782

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  44 in total

1.  Epitopes on proliferating cell nuclear antigen recognized by human lupus autoantibody and murine monoclonal antibody.

Authors:  K Ogata; Y Ogata; Y Takasaki; E M Tan
Journal:  J Immunol       Date:  1987-11-01       Impact factor: 5.422

2.  Impaired late suppression of Epstein-Barr virus (EBV)-induced immunoglobulin synthesis: a common feature of autoimmune disease.

Authors:  A Shore; R Klock; P Lee; K M Snow; E C Keystone
Journal:  J Clin Immunol       Date:  1989-03       Impact factor: 8.317

3.  High titer of antibody to the Epstein-Barr virus membrane antigen in sera from patients with rheumatoid arthritis and systemic lupus erythematosus.

Authors:  T Yokochi; A Yanagawa; Y Kimura; Y Mizushima
Journal:  J Rheumatol       Date:  1989-08       Impact factor: 4.666

4.  Identification of Ki (Ku, p70/p80) autoantigens and analysis of anti-Ki autoantibody reactivity.

Authors:  A M Francoeur; C L Peebles; P T Gompper; E M Tan
Journal:  J Immunol       Date:  1986-03-01       Impact factor: 5.422

5.  Anti-Epstein-Barr virus antibodies in systemic lupus erythematosus.

Authors:  L Origgi; R Perego; C Hu; E Bertetti; P D'Agostino; R Asero; P Riboldi
Journal:  Boll Ist Sieroter Milan       Date:  1988

6.  Detection of antibodies to the Epstein-Barr virus nuclear antigens in the sera from patients with systemic lupus erythematosus.

Authors:  H Kitagawa; S Iho; T Yokochi; T Hoshino
Journal:  Immunol Lett       Date:  1988-03       Impact factor: 3.685

7.  Human T cell responses to the Epstein-Barr nuclear antigen-1 (EBNA-1) as evaluated by synthetic peptides.

Authors:  J Petersen; G Rhodes; K Patrick; J Roudier; J H Vaughan
Journal:  Cell Immunol       Date:  1989-10-15       Impact factor: 4.868

8.  Anti-DNA antibodies from autoimmune mice arise by clonal expansion and somatic mutation.

Authors:  M Shlomchik; M Mascelli; H Shan; M Z Radic; D Pisetsky; A Marshak-Rothstein; M Weigert
Journal:  J Exp Med       Date:  1990-01-01       Impact factor: 14.307

9.  Autoantibodies in infectious mononucleosis have specificity for the glycine-alanine repeating region of the Epstein-Barr virus nuclear antigen.

Authors:  G Rhodes; H Rumpold; P Kurki; K M Patrick; D A Carson; J H Vaughan
Journal:  J Exp Med       Date:  1987-04-01       Impact factor: 14.307

10.  A single germline VH gene segment of normal A/J mice encodes autoantibodies characteristic of systemic lupus erythematosus.

Authors:  Y Naparstek; J André-Schwartz; T Manser; L J Wysocki; L Breitman; B D Stollar; M Gefter; R S Schwartz
Journal:  J Exp Med       Date:  1986-08-01       Impact factor: 14.307

View more
  19 in total

Review 1.  Mechanisms of viral pathogenesis in rheumatic disease.

Authors:  A Perl
Journal:  Ann Rheum Dis       Date:  1999-08       Impact factor: 19.103

2.  Epstein-Barr virus-induced autoimmune responses. I. Immunoglobulin M autoantibodies to proteins mimicking and not mimicking Epstein-Barr virus nuclear antigen-1.

Authors:  J H Vaughan; J R Valbracht; M D Nguyen; H H Handley; R S Smith; K Patrick; G H Rhodes
Journal:  J Clin Invest       Date:  1995-03       Impact factor: 14.808

3.  High affinity cross-reacting mAb generated by minimal mimicry: implications for the pathogenesis of anti-nuclear autoantibodies and immunosuppression.

Authors:  A L Rothermel; D C Altieri
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

Review 4.  The Epstein-Barr virus in autoimmunity.

Authors:  J H Vaughan
Journal:  Springer Semin Immunopathol       Date:  1995

5.  Epstein-Barr virus infection is common in inflamed gastrointestinal mucosa.

Authors:  Julie L Ryan; You-Jun Shen; Douglas R Morgan; Leigh B Thorne; Shannon C Kenney; Ricardo L Dominguez; Margaret L Gulley
Journal:  Dig Dis Sci       Date:  2012-03-13       Impact factor: 3.199

6.  Distribution and phenotype of Epstein-Barr virus-infected cells in inflammatory bowel disease.

Authors:  T Spieker; H Herbst
Journal:  Am J Pathol       Date:  2000-07       Impact factor: 4.307

Review 7.  Mechanisms of lymphatic system-specific viral replication and its potential role in autoimmune disease.

Authors:  S-K Friedrich; P A Lang; J Friebus-Kardash; V Duhan; J Bezgovsek; K S Lang
Journal:  Clin Exp Immunol       Date:  2019-01       Impact factor: 4.330

8.  Clinical effects of infusing anti-Epstein-Barr virus (EBV)-specific cytotoxic T-lymphocytes into patients with severe chronic active EBV infection.

Authors:  Masao Hagihara; Takahide Tsuchiya; Osamu Hyodo; Yoko Ueda; Kei Tazume; Aya Masui; Ayako Kanemura; Fumiaki Yoshiba; Shinji Takashimizu; Shohei Matzusaki; Shunichi Kato; Tomomitsu Hotta
Journal:  Int J Hematol       Date:  2003-07       Impact factor: 2.490

9.  EBV-encoded latent membrane protein 1 cooperates with BAFF/BLyS and APRIL to induce T cell-independent Ig heavy chain class switching.

Authors:  Bing He; Nancy Raab-Traub; Paolo Casali; Andrea Cerutti
Journal:  J Immunol       Date:  2003-11-15       Impact factor: 5.422

10.  Antibodies specific for Epstein-Barr virus nuclear antigen-1 cross-react with human heterogeneous nuclear ribonucleoprotein L.

Authors:  J William Lindsey; Samantha L deGannes; Kimberly A Pate; Xiurong Zhao
Journal:  Mol Immunol       Date:  2015-11-28       Impact factor: 4.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.